메뉴 건너뛰기




Volumn 21, Issue 2, 2014, Pages 109-120

Type 2 diabetes and cardiovascular disease: What next?

Author keywords

cardiovascular disease; neuroendocrine; risk factors; sleep disorders; stress; type 2 diabetes

Indexed keywords

ACETYLSALICYLIC ACID; INSULIN; MELATONIN; ORAL ANTIDIABETIC AGENT;

EID: 84896843454     PISSN: 1752296X     EISSN: 17522978     Source Type: Journal    
DOI: 10.1097/MED.0000000000000044     Document Type: Review
Times cited : (43)

References (127)
  • 1
    • 84886059217 scopus 로고    scopus 로고
    • All-cause and cardiovascular mortality in middle-Aged people with type 2 diabetes compared with people without diabetes in a large UK primary care database
    • Taylor KS, Heneghan CJ, Farmer AJ, et al. All-cause and cardiovascular mortality in middle-Aged people with type 2 diabetes compared with people without diabetes in a large U.K. primary care database. Diabetes Care 2013; 36:2366-2371
    • (2013) Diabetes Care , vol.36 , pp. 2366-2371
    • Taylor, K.S.1    Heneghan, C.J.2    Farmer, A.J.3
  • 2
    • 0032560807 scopus 로고    scopus 로고
    • Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction
    • Haffner SM, Lehto S, Rönnemaa T, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998; 339:229-234
    • (1998) N Engl J Med , vol.339 , pp. 229-234
    • Haffner, S.M.1    Lehto, S.2    Rönnemaa, T.3
  • 3
    • 84871995815 scopus 로고    scopus 로고
    • Standards of medical care in diabetes -2013
    • American Diabetes Association
    • American Diabetes Association. Standards of medical care in diabetes -2013. Diabetes Care 2012; 36:S11-S66
    • (2012) Diabetes Care , vol.36
  • 4
    • 77951735232 scopus 로고    scopus 로고
    • Effects of intensive blood-pressure control in type 2 diabetes mellitus
    • The ACCORD Study Group
    • The ACCORD Study Group. Effects of intensive blood-pressure control in type 2 diabetes mellitus. N Engl J Med 2010; 362:1575-1585
    • (2010) N Engl J Med , vol.362 , pp. 1575-1585
  • 5
    • 34548420712 scopus 로고    scopus 로고
    • Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): A randomised controlled trial
    • Collaborative Group ADVANCE.MacMahon S.et al.
    • Patel A, Collaborative Group ADVANCE, MacMahon S, et al. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): A randomised controlled trial. Lancet 2007; 370:829-840
    • (2007) Lancet , vol.370 , pp. 829-840
    • Patel, A.1
  • 6
    • 77954374543 scopus 로고    scopus 로고
    • Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease
    • Cooper-DeHoff RM, Gong Y, Handberg EM, et al. Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease. J Am Med Assoc 2010; 304:61-68
    • (2010) J Am Med Assoc , vol.304 , pp. 61-68
    • Cooper-DeHoff, R.M.1    Gong, Y.2    Handberg, E.M.3
  • 7
    • 84867144380 scopus 로고    scopus 로고
    • Intensive and standard blood pressure targets in patients with type 2 diabetes mellitus: Systematic review and meta-Analysis
    • McBrien K. Intensive and standard blood pressure targets in patients with type 2 diabetes mellitus: Systematic review and meta-Analysis. Arch Intern Med 2012; 172:1296
    • (2012) Arch Intern Med , vol.172 , pp. 1296
    • McBrien, K.1
  • 8
    • 84880573140 scopus 로고    scopus 로고
    • Blood pressure levels and risk of cardiovascular events and mortality in type-2 diabetes: Cohort study of 34 009 primary care patients
    • Sundström J, Sheikhi R, O ' stgren CJ, et al. Blood pressure levels and risk of cardiovascular events and mortality in type-2 diabetes: Cohort study of 34 009 primary care patients. J Hypertens 2013; 31:1603-1610
    • (2013) J Hypertens , vol.31 , pp. 1603-1610
    • Sundstrom, J.1    Sheikhi, R.2    Ostgren, C.J.3
  • 9
    • 84873881381 scopus 로고    scopus 로고
    • Benefits of early hypertension control on cardiovascular outcomes in patients with diabetes
    • O'Connor PJ, Vazquez-Benitez G, Schmittdiel JA, et al. Benefits of early hypertension control on cardiovascular outcomes in patients with diabetes. Diabetes Care 2012; 36:322-327
    • (2012) Diabetes Care , vol.36 , pp. 322-327
    • O'Connor, P.J.1    Vazquez-Benitez, G.2    Schmittdiel, J.A.3
  • 10
    • 65649106228 scopus 로고    scopus 로고
    • Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: A meta-Analysis of randomised controlled trials
    • Ray KK, Seshasai SRK, Wijesuriya S, et al. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: A meta-Analysis of randomised controlled trials. Lancet 2009; 373:1765-1772
    • (2009) Lancet , vol.373 , pp. 1765-1772
    • Ray, K.K.1    Seshasai, S.R.K.2    Wijesuriya, S.3
  • 11
    • 70349124205 scopus 로고    scopus 로고
    • Systematic review: Glucose control and cardiovascular disease in type 2 diabetes
    • Kelly TN, Bazzano LA, Fonseca VA, et al. Systematic review: Glucose control and cardiovascular disease in type 2 diabetes. Ann Intern Med 2009; 151:394-403
    • (2009) Ann Intern Med , vol.151 , pp. 394-403
    • Kelly, T.N.1    Bazzano, L.A.2    Fonseca, V.A.3
  • 12
    • 79960959816 scopus 로고    scopus 로고
    • Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: Meta-Analysis of randomised controlled trials
    • Boussageon R, Bejan-Angoulvant T, Saadatian-Elahi M, et al. Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: Meta-Analysis of randomised controlled trials. BMJ 2011; 343:d4169-d14169
    • (2011) BMJ , vol.343
    • Boussageon, R.1    Bejan-Angoulvant, T.2    Saadatian-Elahi, M.3
  • 13
    • 84874357500 scopus 로고    scopus 로고
    • Effects of metformin versus glipizide on cardiovascular outcomes in patients with type 2 diabetes and coronary artery disease
    • Hong J, Zhang Y, Lai S, et al. Effects of metformin versus glipizide on cardiovascular outcomes in patients with type 2 diabetes and coronary artery disease. Diabetes Care 2012; 36:1304-1311
    • (2012) Diabetes Care , vol.36 , pp. 1304-1311
    • Hong, J.1    Zhang, Y.2    Lai, S.3
  • 14
    • 0032511566 scopus 로고    scopus 로고
    • Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34
    • Turner RC, Holman RR, Stratton IM, et al. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998; 352:854-865
    • (1998) Lancet , vol.352 , pp. 854-865
    • Turner, R.C.1    Holman, R.R.2    Stratton, I.M.3
  • 15
    • 54949090768 scopus 로고    scopus 로고
    • Cardiovascular outcomes in trials of oral diabetes medications: A systematic review
    • Selvin E, Bolen S, Yeh H-C, et al. Cardiovascular outcomes in trials of oral diabetes medications: A systematic review. Arch Intern Med 2008; 168:2070
    • (2008) Arch Intern Med , vol.168 , pp. 2070
    • Selvin, E.1    Bolen, S.2    Yeh, H.-C.3
  • 16
    • 48649107300 scopus 로고    scopus 로고
    • Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: Results of the diabetes reduction assessment with ramipril and rosiglitazone medication (dream) trial
    • DREAM Trial Investigators
    • DREAM Trial Investigators. Dagenais GR, Gerstein HC, Holman R, et al. Effects of ramipril and rosiglitazone on cardiovascular and renal outcomes in people with impaired glucose tolerance or impaired fasting glucose: Results of the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) trial. Diabetes Care 2008; 31:1007-1014
    • (2008) Diabetes Care , vol.31 , pp. 1007-1014
    • Dagenais, G.R.1    Gerstein, H.C.2    Holman, R.3
  • 17
    • 84883765959 scopus 로고    scopus 로고
    • Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus
    • Scirica BM, Bhatt DL, Braunwald E, et al. Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus. N Engl J Med 2013; 369:1317-1326
    • (2013) N Engl J Med , vol.369 , pp. 1317-1326
    • Scirica, B.M.1    Bhatt, D.L.2    Braunwald, E.3
  • 18
    • 84883745765 scopus 로고    scopus 로고
    • Alogliptin after acute coronary syndrome in patients with type 2 diabetes
    • White WB, Cannon CP, Heller SR, et al. Alogliptin after acute coronary syndrome in patients with type 2 diabetes. N Engl J Med 2013; 369:1327-1335
    • (2013) N Engl J Med , vol.369 , pp. 1327-1335
    • White, W.B.1    Cannon, C.P.2    Heller, S.R.3
  • 19
    • 84864270406 scopus 로고    scopus 로고
    • Basal insulin and cardiovascular and other outcomes in dysglycemia
    • The ORIGIN Trial Investigators
    • The ORIGIN Trial Investigators. Basal insulin and cardiovascular and other outcomes in dysglycemia. N Engl J Med 2012; 367:319-328
    • (2012) N Engl J Med , vol.367 , pp. 319-328
  • 20
    • 84880323061 scopus 로고    scopus 로고
    • Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes
    • The Look AHEAD Research Group
    • The Look AHEAD Research Group. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med 2013; 369:145-154
    • (2013) N Engl J Med , vol.369 , pp. 145-154
  • 21
    • 84875787136 scopus 로고    scopus 로고
    • Primary prevention of cardiovascular disease with a Mediterranean diet
    • Estruch R, Ros E, Salas-Salvadó J, et al. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med 2013; 368:1279-1290
    • (2013) N Engl J Med , vol.368 , pp. 1279-1290
    • Estruch, R.1    Ros, E.2    Salas-Salvadó, J.3
  • 22
    • 84880003797 scopus 로고    scopus 로고
    • Vegetarian dietary patterns and mortality in Adventist health study 2
    • Orlich MJ. Vegetarian dietary patterns and mortality in Adventist health study 2. JAMA Intern Med 2013; 173:1230
    • (2013) JAMA Intern Med , vol.173 , pp. 1230
    • Orlich, M.J.1
  • 23
    • 84869744919 scopus 로고    scopus 로고
    • Cardiovascular events after bariatric surgery in obese subjects with type 2 diabetes
    • Romeo S, Maglio C, Burza MA, et al. Cardiovascular events after bariatric surgery in obese subjects with type 2 diabetes. Diabetes Care 2012; 35:2613-2617
    • (2012) Diabetes Care , vol.35 , pp. 2613-2617
    • Romeo, S.1    Maglio, C.2    Burza, M.A.3
  • 24
    • 84860136615 scopus 로고    scopus 로고
    • Bariatric surgery versus intensive medical therapy in obese patients with diabetes
    • Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med 2012; 366:1567-1576
    • (2012) N Engl J Med , vol.366 , pp. 1567-1576
    • Schauer, P.R.1    Kashyap, S.R.2    Wolski, K.3
  • 25
    • 84877946805 scopus 로고    scopus 로고
    • Metabolic effects of bariatric surgery in patients with moderate obesity and type 2 diabetes: Analysis of a randomized control trial comparing surgery with intensive medical treatment
    • Kashyap SR, Bhatt DL, Wolski K, et al. Metabolic effects of bariatric surgery in patients with moderate obesity and type 2 diabetes: Analysis of a randomized control trial comparing surgery with intensive medical treatment. Diabetes Care 2013; 36:2175-2182
    • (2013) Diabetes Care , vol.36 , pp. 2175-2182
    • Kashyap, S.R.1    Bhatt, D.L.2    Wolski, K.3
  • 26
    • 84859419232 scopus 로고    scopus 로고
    • Bariatric surgery versus conventional medical therapy for type 2 diabetes
    • Mingrone G, Panunzi S, De Gaetano A, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med 2012; 366:1577-1585
    • (2012) N Engl J Med , vol.366 , pp. 1577-1585
    • Mingrone, G.1    Panunzi, S.2    De Gaetano, A.3
  • 27
    • 84862888250 scopus 로고    scopus 로고
    • Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity
    • Cohen RV, Pinheiro JC, Schiavon CA, et al. Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity. Diabetes Care 2012; 35:1420-1428
    • (2012) Diabetes Care , vol.35 , pp. 1420-1428
    • Cohen, R.V.1    Pinheiro, J.C.2    Schiavon, C.A.3
  • 28
    • 84878534607 scopus 로고    scopus 로고
    • Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension and hyperlipidemia
    • Ikramuddin S, Korner J, Lee W-J, et al. Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension and hyperlipidemia. J Am Med Assoc 2013; 309:2240-2249
    • (2013) J Am Med Assoc , vol.309 , pp. 2240-2249
    • Ikramuddin, S.1    Korner, J.2    Lee, W.-J.3
  • 29
    • 33847675510 scopus 로고    scopus 로고
    • The effect of pioglitazone on recurrent myocardial infarction in 2445 patients with type 2 diabetes and previous myocardial infarction
    • Erdmann E, Dormandy JA, Charbonnel B, et al. The effect of pioglitazone on recurrent myocardial infarction in 2445 patients with type 2 diabetes and previous myocardial infarction. J Am Coll Cardiol 2007; 49:1772-1780
    • (2007) J Am Coll Cardiol , vol.49 , pp. 1772-1780
    • Erdmann, E.1    Dormandy, J.A.2    Charbonnel, B.3
  • 30
    • 33746431474 scopus 로고    scopus 로고
    • Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: The atorvastatin study for prevention of coronary heart disease endpoints in non-insulin-dependent diabetes mellitus (aspen
    • Knopp RH. Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: The Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in Non-Insulin- Dependent Diabetes Mellitus (ASPEN). Diabetes Care 2006; 29:1478-1485
    • (2006) Diabetes Care , vol.29 , pp. 1478-1485
    • Knopp, R.H.1
  • 31
    • 4344683381 scopus 로고    scopus 로고
    • Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): Multicentre randomised placebocontrolled trial
    • Colhoun HM, Betteridge DJ, Durrington PN, et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): Multicentre randomised placebocontrolled trial. Lancet 2004; 364:685-696
    • (2004) Lancet , vol.364 , pp. 685-696
    • Colhoun, H.M.1    Betteridge, D.J.2    Durrington, P.N.3
  • 32
    • 38049033935 scopus 로고    scopus 로고
    • Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: A meta-Analysis
    • Trialists CT. Efficacy of cholesterol-lowering therapy in 18 686 people with diabetes in 14 randomised trials of statins: A meta-Analysis. Lancet 2008; 371:117-125
    • (2008) Lancet , vol.371 , pp. 117-125
    • Trialists, C.T.1
  • 33
    • 77549087054 scopus 로고    scopus 로고
    • Statins and risk of incident diabetes: A collaborative meta-Analysis of randomised statin trials
    • Sattar N, Preiss D, Murray HM, et al. Statins and risk of incident diabetes: A collaborative meta-Analysis of randomised statin trials. Lancet 2010; 375:735-742
    • (2010) Lancet , vol.375 , pp. 735-742
    • Sattar, N.1    Preiss, D.2    Murray, H.M.3
  • 34
    • 84864861863 scopus 로고    scopus 로고
    • Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: An analysis from the JUPITER trial
    • Ridker PM, Pradhan A, MacFadyen JG, et al. Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: An analysis from the JUPITER trial. Lancet 2012; 380:565-571
    • (2012) Lancet , vol.380 , pp. 565-571
    • Ridker, P.M.1    Pradhan, A.2    MacFadyen, J.G.3
  • 35
    • 84875850647 scopus 로고    scopus 로고
    • Meta-Analysis of impact of different types and doses of statins on new-onset diabetes mellitus
    • Navarese EP, Buffon A, Andreotti F, et al. Meta-Analysis of impact of different types and doses of statins on new-onset diabetes mellitus. Am J Cardiol 2013; 111:1123-1130
    • (2013) Am J Cardiol , vol.111 , pp. 1123-1130
    • Navarese, E.P.1    Buffon, A.2    Andreotti, F.3
  • 36
    • 84880265383 scopus 로고    scopus 로고
    • Statin therapy on glycaemic control in type 2 diabetes: A meta-Analysis
    • Zhou Y, Yuan Y, Cai R-R, et al. Statin therapy on glycaemic control in type 2 diabetes: A meta-Analysis. Expert Opin Pharmacother 2013; 14:1575-1584
    • (2013) Expert Opin Pharmacother , vol.14 , pp. 1575-1584
    • Zhou, Y.1    Yuan, Y.2    Cai, R.-R.3
  • 37
    • 0035856017 scopus 로고    scopus 로고
    • Diet, lifestyle, and the risk of type 2 diabetes mellitus in women
    • Hu FB, Manson JE, Stampfer MJ, et al. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 2001; 345:790-797
    • (2001) N Engl J Med , vol.345 , pp. 790-797
    • Hu, F.B.1    Manson, J.E.2    Stampfer, M.J.3
  • 38
    • 34249896659 scopus 로고    scopus 로고
    • Effect of bmi on lifetime risk for diabetes in the US
    • Narayan KMV, Boyle JP, Thompson TJ, et al. Effect of BMI on lifetime risk for diabetes in the U.S. Diabetes Care 2007; 30:1562-1566
    • (2007) Diabetes Care , vol.30 , pp. 1562-1566
    • Narayan, K.M.V.1    Boyle, J.P.2    Thompson, T.J.3
  • 39
    • 84866395319 scopus 로고    scopus 로고
    • Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults
    • Neeland IJ, Turer AT, Ayers MCR, et al. Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults. J Am Med Assoc 2012; 308:1150
    • (2012) J Am Med Assoc , vol.308 , pp. 1150
    • Neeland, I.J.1    Turer, A.T.2    Ayers, M.C.R.3
  • 40
    • 0017348197 scopus 로고
    • Relation of body weight to development of ischemic heart disease in a cohort of young north american men after a 26 year observation period: The manitoba study
    • Rabkin SW, Mathewson FA, Hsu P-H. Relation of body weight to development of ischemic heart disease in a cohort of young North American men after a 26 year observation period: The Manitoba Study. Am J Cardiol 1977; 39:452-458
    • (1977) Am J Cardiol , vol.39 , pp. 452-458
    • Rabkin, S.W.1    Mathewson, F.A.2    Hsu, P.-H.3
  • 41
    • 0020533259 scopus 로고
    • Obesity as an independent risk factor for cardiovascular disease: A 26-year follow-up of participants in the FraminghamHeart Study
    • Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular disease: A 26-year follow-up of participants in the FraminghamHeart Study. Circulation 1983; 67:968-977
    • (1983) Circulation , vol.67 , pp. 968-977
    • Hubert, H.B.1    Feinleib, M.2    McNamara, P.M.3    Castelli, W.P.4
  • 42
    • 0037048167 scopus 로고    scopus 로고
    • Overweight and obesity as determinants of cardiovascular risk: The Framingham experience
    • Wilson PWF, D'Agostino RB, Sullivan L, et al. Overweight and obesity as determinants of cardiovascular risk: The Framingham experience. Arch Intern Med 2002; 162:1867-1872
    • (2002) Arch Intern Med , vol.162 , pp. 1867-1872
    • Wilson, P.W.F.1    D'Agostino, R.B.2    Sullivan, L.3
  • 43
    • 33845886915 scopus 로고    scopus 로고
    • Abdominal obesity and metabolic syndrome
    • Despre s J-P, Lemieux I. Abdominal obesity and metabolic syndrome. Nature 2006; 444:881-887
    • (2006) Nature , vol.444 , pp. 881-887
    • Despres, J.-P.1    Lemieux, I.2
  • 44
    • 33845881411 scopus 로고    scopus 로고
    • Mechanisms linking obesity to insulin resistance and type 2 diabetes
    • Kahn SE, Hull RL, Utzschneider KM. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006; 444:840-846
    • (2006) Nature , vol.444 , pp. 840-846
    • Kahn, S.E.1    Hull, R.L.2    Utzschneider, K.M.3
  • 45
    • 33845864967 scopus 로고    scopus 로고
    • Adipocytes as regulators of energy balance and glucose homeostasis
    • Rosen ED, Spiegelman BM. Adipocytes as regulators of energy balance and glucose homeostasis. Nature 2006; 444:847-853
    • (2006) Nature , vol.444 , pp. 847-853
    • Rosen, E.D.1    Spiegelman, B.M.2
  • 46
    • 18044366410 scopus 로고    scopus 로고
    • Adipokines: Molecular links between obesity and atheroslcerosis
    • Lau DCW. Adipokines: Molecular links between obesity and atheroslcerosis. AJP Heart Circ Physiol 2005; 288:H2031-H2041
    • (2005) AJP Heart Circ Physiol , vol.288
    • Lau, D.C.W.1
  • 47
    • 2942720515 scopus 로고    scopus 로고
    • Beneficial cardiovascular pleiotropic effects of statins
    • Davignon J. Beneficial cardiovascular pleiotropic effects of statins. Circulation 2004; 109:III-39-III-43
    • (2004) Circulation , vol.109
    • Davignon, J.1
  • 48
    • 84880323061 scopus 로고    scopus 로고
    • Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes
    • The Look AHEAD Research Group
    • The Look AHEAD Research Group. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med 2013; 369:145-154
    • (2013) N Engl J Med , vol.369 , pp. 145-154
  • 49
    • 34548090763 scopus 로고    scopus 로고
    • Effects of bariatric surgery on mortality in Swedish obese subjects
    • Sjostrom L, Narbro K, Sjoström CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007; 357:741-752
    • (2007) N Engl J Med , vol.357 , pp. 741-752
    • Sjostrom, L.1    Narbro, K.2    Sjostrom, C.D.3
  • 50
    • 84865293878 scopus 로고    scopus 로고
    • Bariatric surgery and prevention of type 2 diabetes in swedish obese subjects
    • Carlsson LMS, Peltonen M, Ahlin S, et al. Bariatric surgery and prevention of type 2 diabetes in swedish obese subjects. N Engl J Med 2012; 367:695-704
    • (2012) N Engl J Med , vol.367 , pp. 695-704
    • Carlsson, L.M.S.1    Peltonen, M.2    Ahlin, S.3
  • 51
    • 84855367738 scopus 로고    scopus 로고
    • Bariatric surgery and long-Term cardiovascular events
    • Sjostrom L, Peltonen M, Jacobson P, et al. Bariatric surgery and long-Term cardiovascular events. J Am Med Assoc 2012; 307:56-65
    • (2012) J Am Med Assoc , vol.307 , pp. 56-65
    • Sjostrom, L.1    Peltonen, M.2    Jacobson, P.3
  • 52
    • 84878562914 scopus 로고    scopus 로고
    • Bariatric surgery for weight loss and glycemic control in nonmorbidly obese adults with diabetes
    • Maggard-Gibbons M,Maglione M, Livhits M, et al. Bariatric surgery for weight loss and glycemic control in nonmorbidly obese adults with diabetes. J Am Med Assoc 2013; 309:2250-2261
    • (2013) J Am Med Assoc , vol.309 , pp. 2250-2261
    • Maggard-Gibbons, M.1    Maglione, M.2    Livhits, M.3
  • 53
    • 84865991696 scopus 로고    scopus 로고
    • All bariatric surgeries are not created equal: Insights from mechanistic comparisons
    • Stefater MA, Wilson-Perez HE, Chambers AP, et al. All bariatric surgeries are not created equal: Insights from mechanistic comparisons. Endocr Rev 2012; 33:595-622
    • (2012) Endocr Rev , vol.33 , pp. 595-622
    • Stefater, M.A.1    Wilson-Perez, H.E.2    Chambers, A.P.3
  • 54
    • 84866738529 scopus 로고    scopus 로고
    • Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome
    • e7
    • Vrieze A, Van Nood E, Holleman F, et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 2012; 143:913-916; e7
    • (2012) Gastroenterology , vol.143 , pp. 913-916
    • Vrieze, A.1    Van Nood, E.2    Holleman, F.3
  • 55
    • 84879084313 scopus 로고    scopus 로고
    • Excess risk of mortality and cardiovascular events associated with smoking among patients with diabetes: Meta-Analysis of observational prospective studies
    • Qin R, Chen T, Lou Q, Yu D. Excess risk of mortality and cardiovascular events associated with smoking among patients with diabetes: Meta-Analysis of observational prospective studies. Int J Cardiol 2013; 167:342-350
    • (2013) Int J Cardiol , vol.167 , pp. 342-350
    • Qin, R.1    Chen, T.2    Lou, Q.3    Yu, D.4
  • 56
    • 0037060001 scopus 로고    scopus 로고
    • Smoking and risk of coronary heart disease among women with type 2 diabetes mellitus
    • Al-Delaimy WK, Manson JE, Solomon CG, et al. Smoking and risk of coronary heart disease among women with type 2 diabetes mellitus. Arch Intern Med 2002; 162:273-279
    • (2002) Arch Intern Med , vol.162 , pp. 273-279
    • Al-Delaimy, W.K.1    Manson, J.E.2    Solomon, C.G.3
  • 57
    • 84874914477 scopus 로고    scopus 로고
    • Association of smoking cessation and weight change with cardiovascular disease among adults with and without diabetes
    • Clair C. Association of smoking cessation and weight change with cardiovascular disease among adults with and without diabetes. J Am Med Assoc 2013; 309:1014
    • (2013) J Am Med Assoc , vol.309 , pp. 1014
    • Clair, C.1
  • 58
    • 56149113603 scopus 로고    scopus 로고
    • Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes
    • Ogawa H, Nakayama M, Morimoto T, et al. Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes. J Am Med Assoc 2008; 300:2134-2141
    • (2008) J Am Med Assoc , vol.300 , pp. 2134-2141
    • Ogawa, H.1    Nakayama, M.2    Morimoto, T.3
  • 59
    • 55949127696 scopus 로고    scopus 로고
    • The prevention of progression of arterial disease and diabetes (POPADAD) trial: Factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease
    • Belch J, MacCuish A, Campbell I, et al. The prevention of progression of arterial disease and diabetes (POPADAD) trial: Factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease. BMJ 2008; 337:a1840-A11840
    • (2008) BMJ , vol.337
    • Belch, J.1    MacCuish, A.2    Campbell, I.3
  • 61
    • 71749105108 scopus 로고    scopus 로고
    • Aspirin for primary prevention of cardiovascular events in people with diabetes: Meta-Analysis of randomised controlled trials
    • De Berardis G, Sacco M, Strippoli GFM, et al. Aspirin for primary prevention of cardiovascular events in people with diabetes: Meta-Analysis of randomised controlled trials. BMJ 2009; 339:b4531-b14531
    • (2009) BMJ , vol.339
    • De Berardis, G.1    Sacco, M.2    Strippoli, G.F.M.3
  • 62
    • 35348816110 scopus 로고    scopus 로고
    • Aspirin and Simvastatin Combination for Cardiovascular Events Prevention Trial in Diabetes (ACCEPT-D): Design of a randomized study of the efficacy of low-dose aspirin in the prevention of cardiovascular events in subjects with diabetes mellitus treated with statins
    • De Berardis G, Sacco M, Evangelista V, et al. Aspirin and Simvastatin Combination for Cardiovascular Events Prevention Trial in Diabetes (ACCEPT-D): Design of a randomized study of the efficacy of low-dose aspirin in the prevention of cardiovascular events in subjects with diabetes mellitus treated with statins. Trials 2007; 8:21
    • (2007) Trials , vol.8 , pp. 21
    • De Berardis, G.1    Sacco, M.2    Evangelista, V.3
  • 63
    • 84859005222 scopus 로고    scopus 로고
    • Jane M Armitage BSc MBBS MRCP FFPH Clinical Trial Service Unit University of Oxford Internet].
    • Jane M Armitage, BSc, MBBS, MRCP, FFPH, Clinical Trial Service Unit, University of Oxford. A study of cardiovascular events in diabetes [Internet]. http://clinicaltrials.gov/ct2/show/NCT00135226
    • A study of cardiovascular events in diabetes
  • 64
    • 84862006679 scopus 로고    scopus 로고
    • Prevalence of diagnosed sleep apnea among patients with type 2 diabetes in primary care
    • Heffner JE. Prevalence of diagnosed sleep apnea among patients with type 2 diabetes in primary care. Chest J 2012; 141:1414
    • (2012) Chest J , vol.141 , pp. 1414
    • Heffner, J.E.1
  • 65
    • 70349776890 scopus 로고    scopus 로고
    • A randomized study on the effect of weight loss on obstructive sleep apnea among obese patients with type 2 diabetes: The Sleep AHEAD study
    • Foster GD, Borradaile KE, Sanders MH, et al. A randomized study on the effect of weight loss on obstructive sleep apnea among obese patients with type 2 diabetes: The Sleep AHEAD study. Arch Intern Med 2009; 169:1619
    • (2009) Arch Intern Med , vol.169 , pp. 1619
    • Foster, G.D.1    Borradaile, K.E.2    Sanders, M.H.3
  • 66
    • 84861375972 scopus 로고    scopus 로고
    • Association between treated and untreated obstructive sleep apnea and risk of hypertension
    • Agusti A. Association between treated and untreated obstructive sleep apnea and risk of hypertension. J Am Med Assoc 2012; 307:2169
    • (2012) J Am Med Assoc , vol.307 , pp. 2169
    • Agusti, A.1
  • 68
    • 84988859542 scopus 로고    scopus 로고
    • Institute of Medicine (U.S.), Committee on Sleep Medicine and Research [Internet]. Washington, DC: National Academies Press Accessed 11 October 2013]
    • Colten HR, Altevogt BM, Institute of Medicine (U.S.), Committee on Sleep Medicine and Research. Sleep disorders and sleep deprivation: An unmet public health problem [Internet]. Washington, DC: National Academies Press; 2006. http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=nap 11617. [Accessed 11 October 2013]
    • (2006) Sleep Disorders And Sleep Deprivation: An Unmet Public Health Problem
    • Colten, H.R.1    Altevogt, B.M.2
  • 69
    • 84873917996 scopus 로고    scopus 로고
    • Sleep loss due to worry and future risk of cardiovascular disease and all-cause mortality: The Scottish Health Survey
    • Hamer M, Batty GD, Kivimaki M. Sleep loss due to worry and future risk of cardiovascular disease and all-cause mortality: The Scottish Health Survey. Eur J Prev Cardiol 2011; 19:1437-1443
    • (2011) Eur J Prev Cardiol , vol.19 , pp. 1437-1443
    • Hamer, M.1    Batty, G.D.2    Kivimaki, M.3
  • 70
    • 84859998099 scopus 로고    scopus 로고
    • Sleep duration, snoring habits, and cardiovascular disease risk factors in an ethnically diverse population
    • Mosca M, Aggarwal B. Sleep duration, snoring habits, and cardiovascular disease risk factors in an ethnically diverse population. J Cardiovasc Nurs 2012; 27:263-269
    • (2012) J Cardiovasc Nurs , vol.27 , pp. 263-269
    • Mosca, M.1    Aggarwal, B.2
  • 71
    • 12744278427 scopus 로고    scopus 로고
    • Associations of frequent sleep insufficiency with health-related quality of life and health behaviors
    • Strine TW, Chapman DP. Associations of frequent sleep insufficiency with health-related quality of life and health behaviors. Sleep Med 2005; 6:23-27
    • (2005) Sleep Med , vol.6 , pp. 23-27
    • Strine, T.W.1    Chapman, D.P.2
  • 72
    • 70349743696 scopus 로고    scopus 로고
    • Effects of meal habits and alcohol/cigarette consumption on morningness-eveningness preference and sleep habits by Japanese female students aged 18-29
    • Nakade M, Takeuchi H, Kurotani M, Harada T. Effects of meal habits and alcohol/cigarette consumption on morningness-eveningness preference and sleep habits by Japanese female students aged 18-29. J Physiol Anthropol 2009; 28:83-90
    • (2009) J Physiol Anthropol , vol.28 , pp. 83-90
    • Nakade, M.1    Takeuchi, H.2    Kurotani, M.3    Harada, T.4
  • 73
    • 84896887517 scopus 로고    scopus 로고
    • National Sleep Foundation Internet]. Accessed 11 October 2013]
    • National Sleep Foundation. Sleep and exercise in America 2013 [Internet]. http://www.sleepfoundation.org. [Accessed 11 October 2013]
    • (2013) Sleep and exercise in America
  • 74
    • 84872599357 scopus 로고    scopus 로고
    • Bidirectional associations between insomnia symptoms and unhealthy behaviours: Insomnia symptoms and unhealthy behaviours
    • Haario P, Rahkonen O, Laaksonen M, et al. Bidirectional associations between insomnia symptoms and unhealthy behaviours: Insomnia symptoms and unhealthy behaviours. J Sleep Res 2013; 22:89-95
    • (2013) J Sleep Res , vol.22 , pp. 89-95
    • Haario, P.1    Rahkonen, O.2    Laaksonen, M.3
  • 75
    • 0004193830 scopus 로고    scopus 로고
    • National Sleep Foundation Internet]. Accessed 11 October 2013]
    • National Sleep Foundation. Sleep in America 2011 [Internet]. http:// www.sleepfoundation.org. [Accessed 11 October 2013]
    • (2011) Sleep in America
  • 77
    • 36048935089 scopus 로고    scopus 로고
    • Short sleep duration across income, education, and race/ethnic groups: Population prevalence and growing disparities during 34 years of follow-up
    • Stamatakis KA, Kaplan GA, Roberts RE. Short sleep duration across income, education, and race/ethnic groups: Population prevalence and growing disparities during 34 years of follow-up. Ann Epidemiol 2007; 17:948-955
    • (2007) Ann Epidemiol , vol.17 , pp. 948-955
    • Stamatakis, K.A.1    Kaplan, G.A.2    Roberts, R.E.3
  • 78
    • 43749124679 scopus 로고    scopus 로고
    • Associations of usual sleep duration with serum lipid and lipoprotein levels
    • Kaneita Y, Uchiyama M, Yoshiike N, Ohida T. Associations of usual sleep duration with serum lipid and lipoprotein levels. Sleep 2008; 31:645
    • (2008) Sleep , vol.31 , pp. 645
    • Kaneita, Y.1    Uchiyama, M.2    Yoshiike, N.3    Ohida, T.4
  • 79
    • 77956367532 scopus 로고    scopus 로고
    • Sleep restriction for 1 week reduces insulin sensitivity in healthy men
    • Buxton OM, Pavlova M, Reid EW, et al. Sleep restriction for 1 week reduces insulin sensitivity in healthy men. Diabetes 2010; 59:2126-2133
    • (2010) Diabetes , vol.59 , pp. 2126-2133
    • Buxton, O.M.1    Pavlova, M.2    Reid, E.W.3
  • 80
    • 84868325661 scopus 로고    scopus 로고
    • Impaired insulin signaling in human adipocytes after experimental sleep restriction: A randomized, crossover study
    • Broussard JL, Ehrmann DA, Van Cauter E, et al. Impaired insulin signaling in human adipocytes after experimental sleep restriction: A randomized, crossover study. Ann Intern Med 2012; 157:549-557
    • (2012) Ann Intern Med , vol.157 , pp. 549-557
    • Broussard, J.L.1    Ehrmann, D.A.2    Van Cauter, E.3
  • 81
    • 75149137910 scopus 로고    scopus 로고
    • Quantity and quality of sleep and incidence of type 2 diabetes: A systematic review and meta-Analysis
    • Cappuccio FP, D'Elia L, Strazzullo P, Miller MA. Quantity and quality of sleep and incidence of type 2 diabetes: A systematic review and meta-Analysis. Diabetes Care 2009; 33:414-420
    • (2009) Diabetes Care , vol.33 , pp. 414-420
    • Cappuccio, F.P.1    D'Elia, L.2    Strazzullo, P.3    Miller, M.A.4
  • 82
    • 33748789576 scopus 로고    scopus 로고
    • Role of sleep duration and quality in the risk and severity of type 2 diabetes mellitus
    • Knutson KL, Ryden AM,Mander BA, Van Cauter E. Role of sleep duration and quality in the risk and severity of type 2 diabetes mellitus. Arch Intern Med 2006; 166:1768
    • (2006) Arch Intern Med , vol.166 , pp. 1768
    • Knutson, K.L.1    Ryden, A.M.2    Mander, B.A.3    Van Cauter, E.4
  • 83
    • 10044287245 scopus 로고    scopus 로고
    • Brief communication: Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite
    • Spiegel K, Tasali E, Penev P, Van Cauter E. Brief communication: Sleep curtailment in healthy young men is associated with decreased leptin levels, elevated ghrelin levels, and increased hunger and appetite. Ann Intern Med 2004; 141:846-850
    • (2004) Ann Intern Med , vol.141 , pp. 846-850
    • Spiegel, K.1    Tasali, E.2    Penev, P.3    Van Cauter, E.4
  • 84
    • 33744971827 scopus 로고    scopus 로고
    • Sleep duration as a risk factor for the development of type 2 diabetes
    • Yaggi HK, Araujo AB, McKinlay JB. Sleep duration as a risk factor for the development of type 2 diabetes. Diabetes Care 2006; 29:657-661
    • (2006) Diabetes Care , vol.29 , pp. 657-661
    • Yaggi, H.K.1    Araujo, A.B.2    McKinlay, J.B.3
  • 85
    • 84870548261 scopus 로고    scopus 로고
    • Sleep duration versus sleep insufficiency as predictors of cardiometabolic health outcomes
    • Altman NG, Izci-Balserak B, Schopfer E, et al. Sleep duration versus sleep insufficiency as predictors of cardiometabolic health outcomes. Sleep Med 2012; 13:1261-1270
    • (2012) Sleep Med , vol.13 , pp. 1261-1270
    • Altman, N.G.1    Izci-Balserak, B.2    Schopfer, E.3
  • 86
    • 0029889941 scopus 로고    scopus 로고
    • Effects of insufficient sleep on blood pressure monitored by a new multibiomedical recorder
    • Tochikubo O, Ikeda A, Miyajima E, Ishii M. Effects of insufficient sleep on blood pressure monitored by a new multibiomedical recorder. Hypertension 1996; 27:1318-1324
    • (1996) Hypertension , vol.27 , pp. 1318-1324
    • Tochikubo, O.1    Ikeda, A.2    Miyajima, E.3    Ishii, M.4
  • 87
    • 0033017930 scopus 로고    scopus 로고
    • Effects of insufficient sleep on blood pressure in hypertensive patients: A 24-h study
    • Lusardi P, Zoppi A, Preti P, et al. Effects of insufficient sleep on blood pressure in hypertensive patients: A 24-h study. Am J Hypertens 1999; 12:63-68
    • (1999) Am J Hypertens , vol.12 , pp. 63-68
    • Lusardi, P.1    Zoppi, A.2    Preti, P.3
  • 88
    • 84878891052 scopus 로고    scopus 로고
    • Sleep Duration and risk for hypertension in women: Results from The Nurses' Health Study
    • Gangwisch JE, Feskanich D, Malaspina D, et al. Sleep Duration and risk for hypertension in women: Results from The Nurses' Health Study. Am J Hypertens 2013; 26:903-911
    • (2013) Am J Hypertens , vol.26 , pp. 903-911
    • Gangwisch, J.E.1    Feskanich, D.2    Malaspina, D.3
  • 89
    • 58149218477 scopus 로고    scopus 로고
    • Short sleep duration and incident coronary artery calcification
    • King CR, Knutson KL, Rathouz PJ, et al. Short sleep duration and incident coronary artery calcification. J Am Med Assoc 2008; 300:2859-2866
    • (2008) J Am Med Assoc , vol.300 , pp. 2859-2866
    • King, C.R.1    Knutson, K.L.2    Rathouz, P.J.3
  • 90
    • 84870663967 scopus 로고    scopus 로고
    • Short sleep duration and type 2 diabetes enhance the risk of cardiovascular events in hypertensive patients
    • Eguchi K, Hoshide S, Ishikawa S, et al. Short sleep duration and type 2 diabetes enhance the risk of cardiovascular events in hypertensive patients. Diabetes Res Clin Pract 2012; 98:518-523
    • (2012) Diabetes Res Clin Pract , vol.98 , pp. 518-523
    • Eguchi, K.1    Hoshide, S.2    Ishikawa, S.3
  • 91
    • 78649780868 scopus 로고    scopus 로고
    • Insufficient rest or sleep and its relation to cardiovascular disease, diabetes and obesity in a national, multiethnic sample
    • Shankar A, Syamala S, Kalidindi S. Insufficient rest or sleep and its relation to cardiovascular disease, diabetes and obesity in a national, multiethnic sample. PLoS One 2010; 5:e14189
    • (2010) PLoS One , vol.5
    • Shankar, A.1    Syamala, S.2    Kalidindi, S.3
  • 92
    • 80655144757 scopus 로고    scopus 로고
    • Sleep duration and sleep quality in relation to 12-year cardiovascular disease incidence: The MORGEN Study
    • Hoevenaar-Blom MP, Spijkerman AMW, Kromhout D, et al. Sleep duration and sleep quality in relation to 12-year cardiovascular disease incidence: The MORGEN Study. Sleep 2011; 34:1487-1492
    • (2011) Sleep , vol.34 , pp. 1487-1492
    • Hoevenaar-Blom, M.P.1    Spijkerman, A.M.W.2    Kromhout, D.3
  • 93
    • 84885873793 scopus 로고    scopus 로고
    • Sufficient sleep duration contributes to lower cardiovascular disease risk in addition to four traditional lifestyle factors: The MORGEN study
    • Hoevenaar-Blom MP, Spijkerman AM, Kromhout D, Verschuren WM. Sufficient sleep duration contributes to lower cardiovascular disease risk in addition to four traditional lifestyle factors: The MORGEN study. Eur J Prev Cardiol 2013; 0:1-9
    • (2013) Eur J Prev Cardiol , vol.0 , pp. 1-9
    • Hoevenaar-Blom, M.P.1    Spijkerman, A.M.2    Kromhout, D.3    Verschuren, W.M.4
  • 94
    • 80053183010 scopus 로고    scopus 로고
    • Synergism between melatonin and atorvastatin against endothelial cell damage induced by lipopolysaccharide: Melatonin improves atorvastatin effects
    • Dayoub JC, Ortiz F, Lopez LC, et al. Synergism between melatonin and atorvastatin against endothelial cell damage induced by lipopolysaccharide: Melatonin improves atorvastatin effects. J Pineal Res 2011; 51:324-330
    • (2011) J Pineal Res , vol.51 , pp. 324-330
    • Dayoub, J.C.1    Ortiz, F.2    Lopez, L.C.3
  • 95
    • 84883739426 scopus 로고    scopus 로고
    • JAK2/STAT3 activation by melatonin attenuates the mitochondrial oxidative damage induced by myocardial ischemia/reper fusion injury
    • Yang Y, Duan W, Jin Z, et al. JAK2/STAT3 activation by melatonin attenuates the mitochondrial oxidative damage induced by myocardial ischemia/reper fusion injury. J Pineal Res 2013; 55:275-286
    • (2013) J Pineal Res , vol.55 , pp. 275-286
    • Yang, Y.1    Duan, W.2    Jin, Z.3
  • 96
    • 36849008650 scopus 로고    scopus 로고
    • Cardiovascular diseases: Protective effects of melatonin
    • Tengattini S, Reiter RJ, Tan D-X, et al. Cardiovascular diseases: Protective effects of melatonin. J Pineal Res 2008; 44:16-25
    • (2008) J Pineal Res , vol.44 , pp. 16-25
    • Tengattini, S.1    Reiter, R.J.2    Tan, D.-X.3
  • 97
    • 0842332600 scopus 로고    scopus 로고
    • Daily nighttime melatonin reduces blood pressure in male patients with essential hypertension
    • Scheer FAJL, Van Montfrans GA, van Someren EJW, et al. Daily nighttime melatonin reduces blood pressure in male patients with essential hypertension. Hypertension 2004; 43:192-197
    • (2004) Hypertension , vol.43 , pp. 192-197
    • Scheer, F.A.J.L.1    Van Montfrans, G.A.2    Van Someren, E.J.W.3
  • 98
    • 84857654651 scopus 로고    scopus 로고
    • Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes
    • Bonnefond A, Clément N, Fawcett K, et al. Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes. Nat Genet 2012; 44:297-301
    • (2012) Nat Genet , vol.44 , pp. 297-301
    • Bonnefond, A.1    Clément, N.2    Fawcett, K.3
  • 99
    • 84875666002 scopus 로고    scopus 로고
    • Melatonin secretion and the incidence of type 2 diabetes
    • McMullan CJ, Schernhammer ES, Rimm EB, et al. Melatonin secretion and the incidence of type 2 diabetes. J Am Med Assoc 2013; 309:1388-1396
    • (2013) J Am Med Assoc , vol.309 , pp. 1388-1396
    • McMullan, C.J.1    Schernhammer, E.S.2    Rimm, E.B.3
  • 100
    • 84859057132 scopus 로고    scopus 로고
    • Racial/ethnic-And education-related disparities in the control of risk factors for cardiovascular disease among individuals with diabetes
    • Chatterji P, Joo H, Lahiri K. Racial/ethnic-And education-related disparities in the control of risk factors for cardiovascular disease among individuals with diabetes. Diabetes Care 2011; 35:305-312
    • (2011) Diabetes Care , vol.35 , pp. 305-312
    • Chatterji, P.1    Joo, H.2    Lahiri, K.3
  • 101
    • 84868111342 scopus 로고    scopus 로고
    • Mortality among low-income African Americans and whites with diabetes
    • Conway BN, May ME, Blot WJ. Mortality among low-income African Americans and whites with diabetes. Diabetes Care 2012; 35:2293-2299
    • (2012) Diabetes Care , vol.35 , pp. 2293-2299
    • Conway, B.N.1    May, M.E.2    Blot, W.J.3
  • 102
    • 84861773982 scopus 로고    scopus 로고
    • Predictors of mortality over 8 years in type 2 diabetic patients: Translating research into action for diabetes (TRIAD
    • McEwen LN, Karter AJ, Waitzfelder BE, et al. Predictors of mortality over 8 years in type 2 diabetic patients: Translating research into action for diabetes (TRIAD). Diabetes Care 2012; 35:1301-1309
    • (2012) Diabetes Care , vol.35 , pp. 1301-1309
    • McEwen, L.N.1    Karter, A.J.2    Waitzfelder, B.E.3
  • 103
    • 84863410716 scopus 로고    scopus 로고
    • Social adaptability index predicts overall mortality in patients with diabetes
    • Goldfarb-Rumyantzev AS, Rout P, Sandhu GS, et al. Social adaptability index predicts overall mortality in patients with diabetes. J Diabetes Complications 2012; 26:44-49
    • (2012) J Diabetes Complications , vol.26 , pp. 44-49
    • Goldfarb-Rumyantzev, A.S.1    Rout, P.2    Sandhu, G.S.3
  • 104
    • 84865618538 scopus 로고    scopus 로고
    • The contribution of stress to the social patterning of clinical and subclinical cvd risk factors in african americans: The jackson heart study
    • Gebreab SY, Diez-Roux AV, Hickson DA, et al. The contribution of stress to the social patterning of clinical and subclinical CVD risk factors in African Americans: The Jackson Heart Study. Soc Sci Med 2012; 75:1697-1707
    • (2012) Soc Sci Med , vol.75 , pp. 1697-1707
    • Gebreab, S.Y.1    Diez-Roux, A.V.2    Hickson, D.A.3
  • 105
    • 80052021350 scopus 로고    scopus 로고
    • Socioeconomic position is positively associated with blood pressure dipping among African-American adults: The Jackson Heart Study
    • Hickson DA, Roux AVD, Wyatt SB, et al. Socioeconomic position is positively associated with blood pressure dipping among African-American adults: The Jackson Heart Study. Am J Hypertens 2011; 24:1015-1021
    • (2011) Am J Hypertens , vol.24 , pp. 1015-1021
    • Hickson, D.A.1    Roux, A.V.D.2    Wyatt, S.B.3
  • 106
    • 4444382796 scopus 로고    scopus 로고
    • Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study
    • Yusuf S, Hawken S, Ounpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): Case-control study. Lancet 2004; 364:937-952
    • (2004) Lancet , vol.364 , pp. 937-952
    • Yusuf, S.1    Hawken, S.2    Ounpuu, S.3
  • 107
    • 4444376006 scopus 로고    scopus 로고
    • Association of psychosocial risk factors with risk of acute myocardial infarction in 11 119 cases and 13 648 controls from 52 countries (the interheart study): Case-control study
    • Rosengren A, Hawken S, Ounpuu S, et al. Association of psychosocial risk factors with risk of acute myocardial infarction in 11 119 cases and 13 648 controls from 52 countries (the INTERHEART study): Case-control study. Lancet 2004; 364:953-962
    • (2004) Lancet , vol.364 , pp. 953-962
    • Rosengren, A.1    Hawken, S.2    Ounpuu, S.3
  • 108
    • 84876965357 scopus 로고    scopus 로고
    • Depression and risk of mortality in individuals with diabetes: A meta-Analysis and systematic review
    • Park M, Katon WJ, Wolf FM. Depression and risk of mortality in individuals with diabetes: A meta-Analysis and systematic review. Gen Hosp Psychiatry 2013; 35:217-225
    • (2013) Gen Hosp Psychiatry , vol.35 , pp. 217-225
    • Park, M.1    Katon, W.J.2    Wolf, F.M.3
  • 109
    • 25444503755 scopus 로고    scopus 로고
    • Allostatic load and health disparities: A theoretical orientation
    • Carlson ED, Chamberlain RM. Allostatic load and health disparities: A theoretical orientation. Res Nurs Health 2005; 28:306-315
    • (2005) Res Nurs Health , vol.28 , pp. 306-315
    • Carlson, E.D.1    Chamberlain, R.M.2
  • 110
    • 0037218317 scopus 로고    scopus 로고
    • The concept of allostasis in biology and biomedicine
    • McEwen BS, Wingfield JC. The concept of allostasis in biology and biomedicine. Horm Behav 2003; 43:2-15
    • (2003) Horm Behav , vol.43 , pp. 2-15
    • McEwen, B.S.1    Wingfield, J.C.2
  • 111
    • 0036752591 scopus 로고    scopus 로고
    • Sex, stress and the hippocampus: Allostasis, allostatic load and the aging process
    • McEwen BS. Sex, stress and the hippocampus: Allostasis, allostatic load and the aging process. Neurobiol Aging 2002; 23:921-939
    • (2002) Neurobiol Aging , vol.23 , pp. 921-939
    • McEwen, B.S.1
  • 112
    • 69449108280 scopus 로고    scopus 로고
    • Stress and disorders of the stress system
    • Chrousos GP. Stress and disorders of the stress system. Nat Rev Endocrinol 2009; 5:374-381
    • (2009) Nat Rev Endocrinol , vol.5 , pp. 374-381
    • Chrousos, G.P.1
  • 113
    • 0032518022 scopus 로고    scopus 로고
    • Protective and damaging effects of stress mediators
    • Flier JS, Underhill LH, McEwen BS. Protective and damaging effects of stress mediators. N Engl J Med 1998; 338:171-179
    • (1998) N Engl J Med , vol.338 , pp. 171-179
    • Flier, J.S.1    Underhill, L.H.2    McEwen, B.S.3
  • 114
    • 0036100789 scopus 로고    scopus 로고
    • Social relationships, gender, and allostatic load across two age cohorts
    • Seeman TE, Singer BH, Ryff CD, et al. Social relationships, gender, and allostatic load across two age cohorts. Psychosom Med 2002; 64:395-406
    • (2002) Psychosom Med , vol.64 , pp. 395-406
    • Seeman, T.E.1    Singer, B.H.2    Ryff, C.D.3
  • 115
    • 79958054541 scopus 로고    scopus 로고
    • Allostatic load in an environmental riskscape: The role of stressors and gender
    • Mair CA, Cutchin MP, Kristen Peek M. Allostatic load in an environmental riskscape: The role of stressors and gender. Health Place 2011; 17:978-987
    • (2011) Health Place , vol.17 , pp. 978-987
    • Mair, C.A.1    Cutchin, M.P.2    Kristen Peek, M.3
  • 116
    • 68549139946 scopus 로고    scopus 로고
    • The pathogenetic role of cortisol in the metabolic syndrome: A hypothesis
    • Anagnostis P, Athyros VG, Tziomalos K, et al. The pathogenetic role of cortisol in the metabolic syndrome: A hypothesis. J Clin Endocrinol Metab 2009; 94:2692-2701
    • (2009) J Clin Endocrinol Metab , vol.94 , pp. 2692-2701
    • Anagnostis, P.1    Athyros, V.G.2    Tziomalos, K.3
  • 117
    • 84876222145 scopus 로고    scopus 로고
    • Diurnal salivary cortisol is associated with body mass index and waist circumference: The multiethnic study of atherosclerosis
    • Champaneri S, Xu X, Carnethon MR, et al. Diurnal salivary cortisol is associated with body mass index and waist circumference: The multiethnic study of atherosclerosis. Obesity 2013; 21:E56-E63
    • (2013) Obesity , vol.21
    • Champaneri, S.1    Xu, X.2    Carnethon, M.R.3
  • 118
    • 84862123233 scopus 로고    scopus 로고
    • Diurnal salivary cortisol and urinary catecholamines are associated with diabetes mellitus: The Multi-Ethnic Study of Atherosclerosis
    • Champaneri S, Xu X, Carnethon MR, et al. Diurnal salivary cortisol and urinary catecholamines are associated with diabetes mellitus: The Multi-Ethnic Study of Atherosclerosis. Metabolism 2012; 61:986-995
    • (2012) Metabolism , vol.61 , pp. 986-995
    • Champaneri, S.1    Xu, X.2    Carnethon, M.R.3
  • 119
    • 36148987598 scopus 로고    scopus 로고
    • A review of the evidence for a neuroendocrine link between stress, depression and diabetes mellitus
    • Golden SH. A review of the evidence for a neuroendocrine link between stress, depression and diabetes mellitus. Curr Diabetes Rev 2007; 3:252-259
    • (2007) Curr Diabetes Rev , vol.3 , pp. 252-259
    • Golden, S.H.1
  • 120
    • 77958506208 scopus 로고    scopus 로고
    • Biological basis of depression in adults with diabetes
    • Champaneri S, Wand GS, Malhotra SS, et al. Biological basis of depression in adults with diabetes. Curr Diab Rep 2010; 10:396-405
    • (2010) Curr Diab Rep , vol.10 , pp. 396-405
    • Champaneri, S.1    Wand, G.S.2    Malhotra, S.S.3
  • 121
    • 80055056240 scopus 로고    scopus 로고
    • Role of the gut in visceral fat inflammation and metabolic disorders
    • Lam YY, Mitchell AJ, Holmes AJ, et al. Role of the gut in visceral fat inflammation and metabolic disorders. Obesity 2011; 19:2113-2120
    • (2011) Obesity , vol.19 , pp. 2113-2120
    • Lam, Y.Y.1    Mitchell, A.J.2    Holmes, A.J.3
  • 122
    • 84861307167 scopus 로고    scopus 로고
    • Pathophysiology of atherosclerosis: The role of inflammation
    • Tousoulis D, Kampoli A-M, Papageorgiou N, et al. Pathophysiology of atherosclerosis: The role of inflammation. Curr Pharm Des 2011; 17:4089-4110
    • (2011) Curr Pharm Des , vol.17 , pp. 4089-4110
    • Tousoulis, D.1    Kampoli, A.-M.2    Papageorgiou, N.3
  • 123
    • 84861303372 scopus 로고    scopus 로고
    • Potential pathogenic inflammatory mechanisms of endothelial dysfunction induced by type 2 diabetes mellitus
    • Kampoli A-M, Tousoulis D, Briasoulis A, et al. Potential pathogenic inflammatory mechanisms of endothelial dysfunction induced by type 2 diabetes mellitus. Curr Pharm Des 2011; 17:4147-4158
    • (2011) Curr Pharm Des , vol.17 , pp. 4147-4158
    • Kampoli, A.-M.1    Tousoulis, D.2    Briasoulis, A.3
  • 124
    • 82355175483 scopus 로고    scopus 로고
    • Trends in the control of risk factors for cardiovascular disease among adults with diagnosed diabetes: Findings from the National Health and Nutrition Examination Survey 1999-2008: Cardiovascular risk factor control
    • Ford ES. Trends in the control of risk factors for cardiovascular disease among adults with diagnosed diabetes: Findings from the National Health and Nutrition Examination Survey 1999-2008-: Cardiovascular risk factor control. J Diabetes 2011; 3:337-347
    • (2011) J Diabetes , vol.3 , pp. 337-347
    • Ford, E.S.1
  • 125
    • 84886083398 scopus 로고    scopus 로고
    • Trends in control of cardiovascular risk factors among US adults with type 2 diabetes from 1999 to 2010: Comparison by prevalent cardiovascular disease status
    • Wong ND, Patao C, Wong K, et al. Trends in control of cardiovascular risk factors among US adults with type 2 diabetes from 1999 to 2010: Comparison by prevalent cardiovascular disease status. Diab Vasc Dis Res 2013; 10:505-513
    • (2013) Diab Vasc Dis Res , vol.10 , pp. 505-513
    • Wong, N.D.1    Patao, C.2    Wong, K.3
  • 126
    • 0347133334 scopus 로고    scopus 로고
    • Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes
    • Saydah SH. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. J Am Med Assoc 2004; 291:335
    • (2004) J Am Med Assoc , vol.291 , pp. 335
    • Saydah, S.H.1
  • 127
    • 84875978032 scopus 로고    scopus 로고
    • Risk factor control for coronary artery disease secondary prevention in large randomized trials
    • Farkouh ME, Boden WE, Bittner V, et al. Risk factor control for coronary artery disease secondary prevention in large randomized trials. J Am Coll Cardiol 2013; 61:1607-1615
    • (2013) J Am Coll Cardiol , vol.61 , pp. 1607-1615
    • Farkouh, M.E.1    Boden, W.E.2    Bittner, V.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.